 | • レポートコード：TPM-C03044 • 出版社/出版日：Transparency Market Research / 2019年1月23日 • レポート形態：英文、PDF、175ページ • 納品方法：Eメール • 産業分類：製薬 |
| Single User | ￥857,660 (USD5,795) | ▷ お問い合わせ |
| Multi User | ￥1,301,660 (USD8,795) | ▷ お問い合わせ |
| Global Site License | ￥1,745,660 (USD11,795) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本資料は、アレルギー用点眼薬の世界市場について調べ、アレルギー用点眼薬の世界規模、市場動向、市場環境、薬剤クラス別（抗ヒスタミン薬、非ステロイド系抗炎症薬、血管収縮薬）分析、タイプ別（季節性・通年性アレルギー性結膜炎、春季カタル、アトピー性角結膜炎、巨大乳頭性結膜炎）分析、流通経路別（院内薬局、小売薬局、オンライン薬局）分析、アメリカ市場規模、ヨーロッパ市場規模、アジア市場規模、日本市場規模、中国市場規模、関連企業情報などをまとめた調査レポートです。 ・序文・調査範囲・調査手法 ・エグゼクティブサマリー ・アレルギー用点眼薬の世界市場動向 ・アレルギー用点眼薬の世界市場環境 ・アレルギー用点眼薬の世界市場規模 ・アレルギー用点眼薬の世界市場規模：薬剤クラス別（抗ヒスタミン薬、非ステロイド系抗炎症薬、血管収縮薬） ・アレルギー用点眼薬の世界市場規模：タイプ別（季節性・通年性アレルギー性結膜炎、春季カタル、アトピー性角結膜炎、巨大乳頭性結膜炎） ・アレルギー用点眼薬の世界市場規模：流通経路別（院内薬局、小売薬局、オンライン薬局） ・アレルギー用点眼薬の世界市場：地域別市場規模・分析 ・アレルギー用点眼薬の北米市場規模・予測 ・アレルギー用点眼薬のアメリカ市場規模・予測 ・アレルギー用点眼薬の中南米市場規模・予測 ・アレルギー用点眼薬のヨーロッパ市場規模・予測 ・アレルギー用点眼薬のアジア市場規模・予測 ・アレルギー用点眼薬の日本市場規模・予測 ・アレルギー用点眼薬の中国市場規模・予測 ・アレルギー用点眼薬のインド市場規模・予測 ・アレルギー用点眼薬の中東市場規模・予測 ・アレルギー用点眼薬のアフリカ市場規模・予測 ・競争状況・関連企業情報 |
Allergy-relieving Eye Drops Market: Overview
This report analyzes the current and future scenario of the global allergy-relieving eye drops market for the period 2018 to 2026. Rise in geriatric population, increased prevalence of ocular disorders, and high unmet medical needs are likely to be major drivers of the global allergy-relieving eye drops market during the forecast period.
The allergy-relieving eye drops market report comprises an elaborate executive summary, including a snapshot that provides information on various segments of the market. It also provides information and data analysis of the global market with respect to segments based on drug class, type, distribution channel, and region. A detailed qualitative analysis of drivers, restraints, and opportunities of the market has been provided in the market overview section. Additionally, the section comprises competitive matrix and profiles of key market players, along with business overview, to project the competitive landscape of the market. The section also provides market attractiveness analysis based on region and market share analysis in terms of key players, thereby presenting a thorough analysis of the overall competitive scenario in the allergy-relieving eye drops market.
Allergy-relieving Eye Drops Market: Key Segments
Based on drug class, the global allergy-relieving eye drops market has been segmented into antihistamines, non-steroidal anti-inflammatory drugs, vasoconstrictors, and others. The segments have been analyzed based on available drugs used for the treatment of allergic conjunctivitis. Based on type, the market has been classified into seasonal and perennial allergic conjunctivitis, vernal keratoconjunctivitis, atopic keratoconjunctivitis, giant papillary conjunctivitis, and others. In terms of distribution channel, the global allergy-relieving eye drops market has been divided into hospital pharmacies, retail, and online sales. Based on market size and forecast for each of these segments have been provided for the period 2018 to 2026, along with their respective CAGR for the forecast period 2016 to 2026, considering 2017 as the base year.
Allergy-relieving Eye Drops Market: Regional Outlook
In terms of region, the global allergy-relieving eye drops market has been segmented into five major regions: North America (the U.S. and Canada), Europe (the U.K., Germany, France, Spain, Italy, and Rest of Europe), Asia Pacific (India, China, Japan, Australia & New Zealand, and Rest of Asia Pacific), Latin America (Brazil, Mexico, and Rest of Latin America), and Middle East & Africa (South Africa, GCC Countries, and Rest of Middle East & Africa). Market size and forecast for each of these regions and the mentioned countries have been provided for the period 2018 to 2026, along with their respective CAGR for the forecast period 2016 to 2026, considering 2017 as the base year. The research study also covers the competitive scenario in these regions.
Companies Mentioned in the Report
The report also profiles major players operating in the global allergy-relieving eye drops market based on various attributes, such as company overview, financial overview, product portfolio, business strategies, and recent developments. The players covered in the report include Allergan Plc., Johnson & Johnson Services, Inc., Pfizer, Inc., F. Hoffmann-La Roche Ltd., Novartis AG, Bausch Health Companies Inc., Regeneron Pharmaceuticals, Inc., and Santen Pharmaceutical Co., Ltd.
The global allergy-relieving eye drops market has been segmented as below:
Allergy-relieving Eye Drops Market, by Drug Class
Antihistamines
Non-steroidal anti-Inflammatory Drugs
Vasoconstrictors
Others
Allergy-relieving Eye Drops Market, by Type
Seasonal and Perennial Allergic Conjunctivitis
Vernal Keratoconjunctivitis
Atopic Keratoconjunctivitis
Giant Papillary Conjunctivitis
Others
Allergy-relieving Eye Drops Market, by Distribution Channel
Hospital Pharmacies
Retail
Online Sales
Allergy-relieving Eye Drops Market, by Region
North America
U.S.
Canada
Europe
U.K.
Germany
France
Italy
Spain
Rest of Europe
Asia Pacific
India
China
Japan
Australia & New Zealand
Rest of Asia Pacific
Latin America
Brazil
Mexico
Rest of Latin America
Middle East & Africa
South Africa
GCC Countries
Rest of Middle East & Africa
1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary: Global Allergy-relieving Eye Drops Market
4. Market Overview
4.1. Introduction
4.1.1. Market Definition
4.1.2. Industry Evolution / Developments
4.2. Overview
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.4. Global Allergy-relieving Eye Drops Market Analysis and Forecast, 2016–2026
4.4.1. Market Revenue Projections (US$ Mn)
4.5. Porter’s Five Force Analysis
5. Market Outlook
5.1. Disease Prevalence & Incidence Rate Globally with Key Countries
5.2. Pipeline Analysis
5.3. Regulatory Scenario by Region
6. Global Allergy-relieving Eye Drops Market Analysis and Forecast, by Drug Class
6.1. Introduction & Definition
6.2. Key Findings / Developments
6.3. Global Allergy-relieving Eye Drops Market Value Forecast, by Drug Class, 2016–2026
6.3.1. Antihistamines
6.3.2. Non-steroidal Anti-inflammatory Drugs
6.3.3. Vasoconstrictors
6.3.4. Others
6.4. Global Allergy-relieving Eye Drops Market Attractiveness, by Drug Class
7. Global Allergy-relieving Eye Drops Market Analysis and Forecast, by Type
7.1. Introduction & Definition
7.2. Key Findings / Developments
7.3. Global Allergy-relieving Eye Drops Market Value Forecast, by Type, 2016–2026
7.3.1. Seasonal and Perennial Allergic Conjunctivitis
7.3.2. Vernal Keratoconjunctivitis
7.3.3. Atopic Keratoconjunctivitis
7.3.4. Giant Papillary Conjunctivitis
7.3.5. Others
7.4. Global Allergy-relieving Eye Drops Market Attractiveness, by Type
8. Global Allergy-relieving Eye Drops Market Analysis and Forecast, by Distribution Channel
8.1. Introduction & Definition
8.2. Key Findings / Developments
8.3. Global Allergy-relieving Eye Drops Market Value Forecast, by Distribution Channel, 2016–2026
8.3.1. Hospital Pharmacies
8.3.2. Retail
8.3.3. Online Sales
8.4. Global Allergy-relieving Eye Drops Market Attractiveness, by Distribution Channel
9. Global Allergy-relieving Eye Drops Market Analysis and Forecast, by Region
9.1. Key Findings
9.2. Global Allergy-relieving Eye Drops Market Value Forecast, by Region
9.2.1. North America
9.2.2. Europe
9.2.3. Asia Pacific
9.2.4. Latin America
9.2.5. Middle East & Africa
9.3. Global Allergy-relieving Eye Drops Market Attractiveness, by Country/Region
10. North America Allergy-relieving Eye Drops Market Analysis and Forecast
10.1. Introduction
10.1.1. Key Findings
10.2. North America Allergy-relieving Eye Drops Market Value Forecast, by Drug Class, 2016–2026
10.2.1. Antihistamines
10.2.2. Non-steroidal Anti-inflammatory Drugs
10.2.3. Vasoconstrictors
10.2.4. Others
10.3. North America Allergy-relieving Eye Drops Market Value Forecast, by Type, 2016–2026
10.3.1. Seasonal and Perennial Allergic Conjunctivitis
10.3.2. Vernal Keratoconjunctivitis
10.3.3. Atopic Keratoconjunctivitis
10.3.4. Giant Papillary Conjunctivitis
10.3.5. Others
10.4. North America Allergy-relieving Eye Drops Market Value Forecast, by Distribution Channel, 2016–2026
10.4.1. Hospital Pharmacies
10.4.2. Retail
10.4.3. Online Sales
10.5. North America Allergy-relieving Eye Drops Market Value Forecast, by Country, 2016–2026
10.5.1. US
10.5.2. Canada
10.6. North America Allergy-relieving Eye Drops Market Attractiveness Analysis
10.6.1. By Drug Class
10.6.2. By Type
10.6.3. By Distribution Channel
10.6.4. By Country
11. Europe Allergy-relieving Eye Drops Market Analysis and Forecast
11.1. Introduction
11.1.1. Key Findings
11.2. Europe Allergy-relieving Eye Drops Market Value Forecast, by Drug Class, 2016–2026
11.2.1. Antihistamines
11.2.2. Non-steroidal Anti-inflammatory Drugs
11.2.3. Vasoconstrictors
11.2.4. Others
11.3. Europe Allergy-relieving Eye Drops Market Value Forecast, by Type, 2016–2026
11.3.1. Seasonal and Perennial Allergic Conjunctivitis
11.3.2. Vernal Keratoconjunctivitis
11.3.3. Atopic Keratoconjunctivitis
11.3.4. Giant Papillary Conjunctivitis
11.3.5. Others
11.4. Europe Allergy-relieving Eye Drops Market Value Forecast, by Distribution Channel, 2016–2026
11.4.1. Hospital Pharmacies
11.4.2. Retail
11.4.3. Online Sales
11.5. Europe Allergy-relieving Eye Drops Market Value Forecast, by Country/Sub-region, 2016–2026
11.5.1. Germany
11.5.2. France
11.5.3. U.K.
11.5.4. Italy
11.5.5. Spain
11.5.6. Rest of Europe
11.6. Europe Allergy-relieving Eye Drops Market Attractiveness Analysis
11.6.1. By Drug Class
11.6.2. By Type
11.6.3. By Distribution Channel
11.6.4. By Country/Sub-region
12. Asia Pacific Allergy-relieving Eye Drops Market Analysis and Forecast
12.1. Introduction
12.1.1. Key Findings
12.2. Asia Pacific Allergy-relieving Eye Drops Market Value Forecast, by Drug Class, 2016–2026
12.2.1. Antihistamines
12.2.2. Non-steroidal Anti-inflammatory Drugs
12.2.3. Vasoconstrictors
12.2.4. Others
12.3. Asia Pacific Allergy-relieving Eye Drops Market Value Forecast, by Type, 2016–2026
12.3.1. Seasonal and Perennial Allergic Conjunctivitis
12.3.2. Vernal Keratoconjunctivitis
12.3.3. Atopic Keratoconjunctivitis
12.3.4. Giant Papillary Conjunctivitis
12.3.5. Others
12.4. Asia Pacific Allergy-relieving Eye Drops Market Value Forecast, by Distribution Channel, 2016–2026
12.4.1. Hospital Pharmacies
12.4.2. Retail
12.4.3. Online Sales
12.5. Asia Pacific Allergy-relieving Eye Drops Market Value Forecast, by Country/Sub-region, 2016–2026
12.5.1. Japan
12.5.2. China
12.5.3. India
12.5.4. Australia & New Zealand
12.5.5. Rest of Asia Pacific
12.6. Asia Pacific Allergy-relieving Eye Drops Market Attractiveness Analysis
12.6.1. By Drug Class
12.6.2. By Type
12.6.3. By Distribution Channel
12.6.4. By Country/Sub-region
13. Latin America Allergy-relieving Eye Drops Market Analysis and Forecast
13.1. Introduction
13.1.1. Key Findings
13.2. Latin America Allergy-relieving Eye Drops Market Value Forecast, by Drug Class, 2016–2026
13.2.1. Antihistamines
13.2.2. Non-steroidal Anti-inflammatory Drugs
13.2.3. Vasoconstrictors
13.2.4. Others
13.3. Latin America Allergy-relieving Eye Drops Market Value Forecast, by Type, 2016–2026
13.3.1. Seasonal and Perennial Allergic Conjunctivitis
13.3.2. Vernal Keratoconjunctivitis
13.3.3. Atopic Keratoconjunctivitis
13.3.4. Giant Papillary Conjunctivitis
13.3.5. Others
13.4. Latin America Allergy-relieving Eye Drops Market Value Forecast, by Distribution Channel, 2016–2026
13.4.1. Hospital Pharmacies
13.4.2. Retail
13.4.3. Online Sales
13.5. Latin America Allergy-relieving Eye Drops Market Value Forecast, by Country/Sub-region, 2016–2026
13.5.1. Brazil
13.5.2. Mexico
13.5.3. Rest of Latin America
13.6. Latin America Allergy-relieving Eye Drops Market Attractiveness Analysis
13.6.1. By Drug Class
13.6.2. By Type
13.6.3. By Distribution Channel
13.6.4. By Country/Sub-region
14. Middle East & Africa Allergy-relieving Eye Drops Market Analysis and Forecast
14.1. Introduction
14.1.1. Key Findings
14.2. Middle East & Africa Allergy-relieving Eye Drops Market Value Forecast, by Drug Class, 2016–2026
14.2.1. Antihistamines
14.2.2. Non-steroidal Anti-inflammatory Drugs
14.2.3. Vasoconstrictors
14.2.4. Others
14.3. Middle East & Africa Allergy-relieving Eye Drops Market Value Forecast, by Type, 2016–2026
14.3.1. Seasonal and Perennial Allergic Conjunctivitis
14.3.2. Vernal Keratoconjunctivitis
14.3.3. Atopic Keratoconjunctivitis
14.3.4. Giant Papillary Conjunctivitis
14.3.5. Others
14.4. Middle East & Africa Allergy-relieving Eye Drops Market Value Forecast, by Distribution Channel, 2016–2026
14.4.1. Hospital Pharmacies
14.4.2. Retail
14.4.3. Online Sales
14.5. Middle East & Africa Allergy-relieving Eye Drops Market Value Forecast, by Country/Sub-region 2016–2026
14.5.1. GCC Countries
14.5.2. Israel
14.5.3. South Africa
14.5.4. Rest of MEA
14.6. Middle East & Africa Allergy-relieving Eye Drops Market Attractiveness Analysis
14.6.1. By Drug Class
14.6.2. By Type
14.6.3. By Distribution Channel
14.6.4. By Country/Sub-region
15. Competition Landscape
15.1. Global Allergy-relieving Eye Drops Market Share Analysis, by Company (2016)
15.2. Company Profiles
15.2.1. Allergan plc.
15.2.1.1. Company Overview (HQ, Business Segments, Employee Strength)
15.2.1.2. Product Portfolio
15.2.1.3. SWOT Analysis
15.2.1.4. Financial Overview
15.2.1.5. Strategic Overview
15.2.2. Novartis AG
15.2.2.1. Company Overview (HQ, Business Segments, Employee Strength)
15.2.2.2. Product Portfolio
15.2.2.3. SWOT Analysis
15.2.2.4. Financial Overview
15.2.2.5. Strategic Overview
15.2.3. Johnson & Johnson Services, Inc.
15.2.3.1. Company Overview (HQ, Business Segments, Employee Strength)
15.2.3.2. Product Portfolio
15.2.3.3. SWOT Analysis
15.2.3.4. Financial Overview
15.2.3.5. Strategic Overview
15.2.4. Pfizer, Inc.
15.2.4.1. Company Overview (HQ, Business Segments, Employee Strength)
15.2.4.2. Product Portfolio
15.2.4.3. SWOT Analysis
15.2.4.4. Financial Overview
15.2.4.5. Strategic Overview
15.2.5. F. Hoffmann-La Roche Ltd.
15.2.5.1. Company Overview (HQ, Business Segments, Employee Strength)
15.2.5.2. Product Portfolio
15.2.5.3. SWOT Analysis
15.2.5.4. Financial Overview
15.2.5.5. Strategic Overview
15.2.6. Bausch Health Companies Inc.
15.2.6.1. Company Overview (HQ, Business Segments, Employee Strength)
15.2.6.2. Product Portfolio
15.2.6.3. SWOT Analysis
15.2.6.4. Financial Overview
15.2.6.5. Strategic Overview
15.2.7. Regeneron Pharmaceuticals, Inc.
15.2.7.1. Company Overview (HQ, Business Segments, Employee Strength)
15.2.7.2. Product Portfolio
15.2.7.3. SWOT Analysis
15.2.7.4. Financial Overview
15.2.7.5. Strategic Overview
15.2.8. Santen Pharmaceutical Co., Ltd.
15.2.8.1. Company Overview (HQ, Business Segments, Employee Strength)
15.2.8.2. Product Portfolio
15.2.8.3. SWOT Analysis
15.2.8.4. Financial Overview
15.2.8.5. Strategic Overview
Table 01: Global Allergy-relieving Eye Drops Market Value (US$ Mn) Forecast, by Drug Class, 2016–2026
Table 02: Global Allergy-relieving Eye Drops Market Value (US$ Mn) Forecast, by Type, 2016–2026
Table 03: Global Allergy-relieving Eye Drops Market Value (US$ Mn) Forecast, by Distribution Channel, 2016–2026
Table 04: Global Allergy-relieving Eye Drops Market Value (US$ Mn) Forecast, by Region, 2016–2026
Table 05: North America Allergy-relieving Eye Drops Market Value (US$ Mn) Forecast, by Country, 2016–2026
Table 06: North America Allergy-relieving Eye Drops Market Value (US$ Mn) Forecast, by Drug Class, 2016–2026
Table 07: North America Allergy-relieving Eye Drops Market Value (US$ Mn) Forecast, by Type, 2016–2026
Table 08: North America Allergy-relieving Eye Drops Market Value (US$ Mn) Forecast, by Distribution Channel, 2016–2026
Table 09: Europe Allergy-relieving Eye Drops Market Value (US$ Mn) Forecast, by Country/Sub-Region, 2016–2026
Table 10: Europe Allergy-relieving Eye Drops Market Value (US$ Mn) Forecast, by Drug Class, 2016–2026
Table 11: Europe Allergy-relieving Eye Drops Market Value (US$ Mn) Forecast, by Type, 2016–2026
Table 12: Europe Allergy-relieving Eye Drops Market Value (US$ Mn) Forecast, by Distribution Channel, 2016–2026
Table 13: Asia Pacific Allergy-relieving Eye Drops Market Value (US$ Mn) Forecast, by Country/Sub-region, 2016–2026
Table 14: Asia Pacific Allergy-relieving Eye Drops Market Value (US$ Mn) Forecast, by Drug Class, 2016–2026
Table 15: Asia Pacific Allergy-relieving Eye Drops Market Value (US$ Mn) Forecast, by Type, 2016–2026
Table 16: Asia Pacific Allergy-relieving Eye Drops Market Value (US$ Mn) Forecast, by Distribution Channel, 2016–2026
Table 17: Latin America Allergy-relieving Eye Drops Market Value (US$ Mn) Forecast, by Country/Sub-region, 2016–2026
Table 18: Latin America Allergy-relieving Eye Drops Market Value (US$ Mn) Forecast, by Drug Class, 2016–2026
Table 19: Latin America Allergy-relieving Eye Drops Market Value (US$ Mn) Forecast, by Type, 2016–2026
Table 20: Latin America Allergy-relieving Eye Drops Market Value (US$ Mn) Forecast, by Distribution Channel, 2016–2026
Table 21: Middle East & Africa Allergy-relieving Eye Drops Market Value (US$ Mn) Forecast, by Country/Sub-region, 2016–2026
Table 22: Middle East & Africa Allergy-relieving Eye Drops Market Value (US$ Mn) Forecast, by Drug Class, 2016–2026
Table 23: Middle East & Africa Allergy-relieving Eye Drops Market Value (US$ Mn) Forecast, by Type, 2016–2026
Table 24: Middle East & Africa Allergy-relieving Eye Drops Market Value (US$ Mn) Forecast, by Distribution Channel, 2016–2026